GW Pharmaceuticals and supplement retailer GNC have reportedly been among the companies meeting recently with a White House division to discuss aspects of CBD regulation.
A company marketing a brain health supplement has been advised by an industry watchdog to discontinue claims associated with protection against traumatic brain injuries and other health endpoints.
The Trump Administration’s attempt to prevent the use of the WeChat app within the United States has sent shock waves through that portion of the US dietary supplement industry involved with trade to and within China, an observer says.
Nutraveris, a software firm that consults on regulatory affairs for nutrition and dietary supplement markets in Europe, has announced that they have launched an online platform for supplement compliance in the United States.
The Federal Trade Commission has issued refunds in a case brought against an herbal based pain relief supplement that the Commission alleged had insufficient backing for its claims.
The Coronavirus pandemic was a wakeup call for many, highlighting how conventional medicine may not have immediate solutions. This is driving consumers to look for alternative solutions, but not everyone is convinced dietary supplements are the answer....
A ‘Regulatory Gap’ exists within the US dietary supplements industry, and recent talk of modernizing the regulations are ways to close that gap, FDA’s Steven Tave said yesterday
The recent upheavals in the United States around race relations has the nation questioning the insidious role prejudice has played in many walks of life. One group is seeking to use that rekindled awareness as added leverage to ensure equal opportunity...
Danish Researchers report that they have developed an ingestible capsule that captured bacteria and other biological samples while passing through the gastrointestinal tract of rats.
The US Food and Drug Administration rejected mid-August a New Dietary Ingredient notification from Phoenix Biotechnology Inc for oleandrin, a constituent of oleander touted as a COVID-19 cure.
A nonprofit group has asked FDA to crack down on the sale of tianeptine, an ingredient that is sold as an antidepressant drug in many markets outside of the United States.
The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.
Nascent hemp/CBD firms are often woefully unprepared for the regulatory compliance side of operating a dietary supplement firm, something an upcoming industry event aims to help fix.
The United States’ ban of China’s popular social media application WeChat is unlikely to severely impact businesses in the dietary supplement industry, according to an industry expert.
A recent study has found that supplements and energy drinks that contain caffeine are associated with a disproportionately high number of serious adverse events.
With the first full season of hemp agriculture in Texas underway, Santé Labs, an Austin-based analytical lab and contract manufacturing development firm, said it is ready to help hemp farmers with reliable THC level testing.
The Natural Products Association said it has worked with Sen. Kevin Cramer, R-ND to introduce a bill that would allow tax-advantaged medical spending accounts to be used for certain categories of dietary supplements.
Nature’s Crops International, manufacturer of Ahiflower oil, an omega-3 rich plant oil, has announced its product has received Health Canada approval for use in foods.
There is an urgent need to provide evidence-based nutrition education to health professionals and this pandemic may be the perfect catalyst for this change.
The Federal Trade Commission charged Golden Sunrise Nutraceutical, Inc. with deceptively advertising an ‘Emergency D-Virus’ treatment as a scientifically proven way to treat COVID-19. The company even went as far as claiming their treatment was ‘FDA accepted.’
Over 70% of Americans take dietary supplements, and by now, most consumers have probably noticed the disclaimer that says "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”
Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...
An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...
FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
The USDA report that will underpin the development of the next set of Dietary Guidelines for Americans reflects a growing and welcome appreciation of the role of dietary supplements, industry observers say.
Making nutrition understandable for everyone is the goal of the Label Wise initiative led by the Council for Responsible Nutrition. That made it a clear choice for this year’s Editors Award for Industry Initiative of the Year.
An additional seven supplement companies have been added recently to the US Food and Drug Administration’s list of firms making allegedly non compliant COVID-19 treatment claims.
The US Food and Drug Administration yesterday launched a website portal it calls a ‘blueprint’ for the full implementation of the Food Safety Modernization Act. The document lays out a plan for actions over the next decade.
After pausing on-site surveillance inspections in March, the Food and Drug Administration plan to resume domestic inspections starting the week of July 20.
The Center for Science in the Public Interest is urging federal authorities to require testing be done in accredited labs and not just to restrict that to the food importation process. It’s a laudable goal but one that might have unintended consequences,...
Recent cyberattacks on a contract lab and a contract manufacturer lay bare the risk all data-based businesses run in a globalized world where threats can come from anywhere and can potentially be motivated by factors beyond mere financial gain.
A new publication from the Botanical Adulterants Prevention Program reveals that as many as 90% of the lavender essential oil products on the market can be considered to be adulterated.
An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.
A recent warning letter reiterates the importance of collecting adverse event reports in order to demonstrate full compliance with federal laws governing the manufacture and sale of dietary supplements.
The US Food and Drug Administration says it will move actively to prevent the worldwide trade in dietary ingredients, food ingredients and whole foods from being restricted because of misplaced coronavirus infection concerns.
UFC fighter Lyman Good claims his multi-vitamin was adulterated with an illegal steroid, causing him to fail a drug test, but according to a judge, he failed to make his case.
Consumers' interest in immune-boosting products remains at an all time high, and manufacturers are rushing to market with products to fill that need, including many botanical formulas.
With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...
A US Food and Drug Administration study reveals that a number of the products it tested labeled as ‘bitter orange’ did not meet label claim for synephrine content and more than 10% contained undeclared synthetic ingredients.